Sho-saiko-to prevents liver fibrosis induced by bile duct ligation in rats

American Journal of Chinese Medicine

Volumn 32, Issue 2, 2004, Pages 195-207

  Chen, Ming Ho ^a   Chen, Jung Chou ^a,b,f   Tsai, Chin Chuan ^a   Wang, Wen Chuang ^c   Chang, De Ching ^d   Lin, Chun Ching ^e   Hsieh, Hsiao Yen ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^c CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^d NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f NONE   (Taiwan)

Author keywords

Bile duct ligation; Bupleurum; Ginger; Ginseng; Glycyrrhiza; Jujube; Liver fibrosis; Pinellia; Scutellaria; Sho saiko to (TJ 9)

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; BUPLEURUM ROOT; COLLAGEN; GAMMA GLUTAMYLTRANSFERASE; GINGER EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; HYDROXYPROLINE; JUJUBE EXTRACT; MATRIX METALLOPROTEINASE; MESSENGER RNA; PINELLIA EXTRACT; PLANT EXTRACT; SCUTELLARIAE RADIX; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; XIAO CHAI HU TANG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; CHINESE MEDICINE; CHOLESTASIS; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVE SITE; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HISTOPATHOLOGY; HYPERBILIRUBINEMIA; JUJUBE; LIVER FIBROSIS; LIVER FUNCTION TEST; MALE; NONHUMAN; PINELLIA; QUANTITATIVE ANALYSIS; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; BILE DUCTS; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE III; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUGS, CHINESE HERBAL; LIGATION; LIVER CIRRHOSIS; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 3543019186     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X04001862     Document Type: Article

References (30)

1. Alcolado, R., M.J.P. Arthur and J.P. Iredale. Pathogenesis of liver fibrosis. Clin. Sci. 92: 103-112, 1997.
2. Amagaya, S., M. Hayakawa, Y. Ogihara and K. Fujiwara. Effect of sho-saiko-to and dai-saiko-to on experimental hepatic fibrosis in rats. J. Med. Pharm. Soc. Wakan-Yaku 5: 137-145, 1988.
3. Araki, N., T. Noda and K. Ogawa. Cytochemical studies on the effect of intraperitoneal and oral administration of a traditional Chinese medicine (Sho-saiko-to) on the D-galactosamine-induced hepatic injuries of rats. Acta Histochem. Cytochem. 21: 439-453, 1988.
4. Benyon, R.C. and M.J.P. Arthur. Extracellular matrix degradation and the role of hepatic stellate cell. Sem. Liver Dis. 21(3): 373-384, 2001.
5. Benyon, R.C., J.P. Iredale, S. Goddard, P.J. Winwood and M.J.P. Arthur. Expression of tissue inhibitor of metalloproteinase 1 and 2 is increased in fibrotic human liver. Gastroenterology 110: 821-831, 1996.
6. Boigk, G., L. Stroedter, H. Herbst and J. Waldschmidt. Silymarin retard collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 26: 643-649, 1997.
7. Chevallier, M., S. Guerret, P. Chossegros and F. Gerard. A histological semi-quantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 20: 349-355, 1994.
8. Cho, J.J., B. Hocher and H. Herbst. An oral endothelin-A receptor antagonist block collagen synthesis and deposition in advanced rat liver fibrosis. Gastroenterology 118: 1169-1178, 2000.
9. Geerts, A. and V. Rogiers. Sho-saiko-to: the right blend of traditional oriental medicine and liver cell biology. Hepatology 29: 282-284, 1999.
10. Gerling, B., M. Becker, J. Waldschmidt, M. Rehmann and D. Schuppan. Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis. J. Hepatol. 25: 79-84, 1996.
11. Gibo, Y., Y. Nakamura, N. Takahashi and H. Inada. Clinical study of sho-saiko-to therapy to the Japanese patients with chroinc hepatitis C. Prog. Med. 14: 217-219, 1994.
12. Iredale, J.P., R.C. Benyon and M.J.P Arthur. Tissure inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 24: 176-184, 1996.
13. Iredale, J.P., G. Murphy, R.M. Hembry, S.L. Friedman and M.J.P. Arthur. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinase-1 (TIMP-1): implication for regulation of matrix degradation in liver fibrosis. J. Clin. Invest. 90: 282-287, 1992.
14. Jia, J.D., M. Bauer, J.J. Cho and M. Ruehl. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen α1 (I) and TIMP-1. J. Hepatol. 35: 392-398, 2001.
15. Kayano, K., I. Sakaida, K. Uchida and K. Okita. Inhibitory effects of the herbal medicine sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cell. J. Hepatol. 29: 642-649, 1998.
16. Koutouras, J., B.H. Billing and P.J. Scheuer. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br. J. Pathol. 65: 305-311, 1984.
17. Lee, H.S., G.T. Huang, L.H. Miau and L.L. Chiou. Expression of matrix metalloproteinases in spontaneous regression of liver fibrosis. Hepatogastroenterology 48: 1114-1117, 2001.
18. Li, D. and S.L. Friedman. Liver fibrogenesis and the role of hepatic stellate: new insight and prospects for therapy. J. Gastroenterol. Hepatol. 14: 618-633, 1999.
19. Miyamura, M., M. Ono, S. Kyotani and Y. Nishioka. Effects of sho-saiko-to extract on fibrosis and regeneration of the liver in rats. J. Pharm. Pharmacol. 50: 97-105, 1998.
20. Ono, M., M. Miyamura, S. Kyotani and T. Saibara. Effect of sho-saiko-to extract on liver fibrosis in relation to the change in hychroxyproline and retinoid levels of the liver in rats. J. Pharm. Pharmacol. 51: 1079-1084, 1999.
21. Parola, M., G. Leonarduzzi, G. Robino, E. Albano, G. Poli and M.U. Dianzani. On the rale of liver damage induced by long standing cholestasis. Free Rad. Biol. Med. 20: 351-359, 1996.
22. Pietrangelo, A., F. Borella and G. Casalgrandi. Antioxidant activity of silybin in vivo during long-term iron overload in rats. Gastroenterology 109: 1941-1949, 1995.
23. Pleobani, M., M.P. Panozzo, D. Basso and M. Paoli. Cytokines and the progression of liver damage in experimental bile duct ligation. Clin. Exp. Pharmacol. Physiol. 26: 358-363, 1999.
24. Rocky, D.C., J.K. Boyles, G. Gabbiani and S.L. Friedman. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J. Submicro. Cytol. Pathol. 24: 193-203, 1992.
25. Sakae, A., H. Masakane, O. Yukio and O. Yasuhiko. Treatment of chronic liver injury in mice by oral administration of Xiao-Chai-Hu-Tang. J. Ethnophrmacol. 25: 181-187, 1989.
26. Sakaida, I., Y. Matsumura, S. Akiyama, K. Hayashi, A. Isguge and K. Okita. Herbal medicine sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rats liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. J. Hepatol. 28: 298-306, 1998.
27. Shimizu, I., Y.R. Ma, Y. Mizobuchi, F. Liu and T. Miura. Effect of sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29: 149-160, 1999.
28. Tsukamato, H. Cytokine regulation of hepatic stellate cell in liver fibrosis. Alcohol Clin. Exp. Res. 23(5): 911-916, 1999.
29. Woessner, J.F. The determination of hydroxyproline in tissue and protein samples containing small proportion of this amino acid. Arch. Biochem. Biophys. 93: 440-447, 1961.
30. Yamashiki, M., A. Nishimura and S. Sakaguchi. Effect of the Japanese herbal medicine "Sho-Saiko-to" as a cytokine inducer. Environ. Toxicol. Pharmacol. 2: 301-306, 1996.